Abstract
These slides were presented by Grace Lee at the ACIP meeting on March 1st 2021.
Objectives:
- Review, evaluate, and interpret post-authorization/approval COVID-19 vaccine safety data
- Serve as the central hub for technical subject matter expertise from federal agencies conducting post-authorization/approval safety monitoring
- Advise on analyses, interpretation, and data presentation
- Provide updates to the ACIP COVID-19 Vaccines Working Group and the ACIP on COVID-19 vaccine safety
Background paper
Americas
United States of America
vaccine safety
COVID-19
